These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 897061)

  • 1. [Sulpiride treatment of schizophrenics. Endocrine effects and aggressivity].
    Di Girolamo F; Rongo CA
    Quad Criminol Clin; 1977; 19(2):237-47. PubMed ID: 897061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An evaluation of a unique new antipsychotic agent, sulpiride: effects on serum prolactin and growth hormone levels.
    Mielke DH; Gallant DM; Kessler C
    Am J Psychiatry; 1977 Dec; 134(12):1371-5. PubMed ID: 21571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulpiride: evaluation of antipsychotic activity in schizophrenic patients.
    Mielke DH; Gallant DM; Roniger JJ; Kessler C; Kessler LR
    Dis Nerv Syst; 1977 Jul; 38(7):569-71. PubMed ID: 326504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulpiride: evaluation of antipsychotic activity in chronic schizophrenic patients.
    Mielke DH; Gallant DM; Roniger JJ; Kessler C
    Psychopharmacol Bull; 1977 Jul; 13(3):40-1. PubMed ID: 18758
    [No Abstract]   [Full Text] [Related]  

  • 5. [Study of visually evoked potentials in schizophrenic patients treated with sulpiride].
    Brosteanu ER; Floru L
    Arzneimittelforschung; 1980; 30(8):1306-9. PubMed ID: 7192148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Difference in prolaction response of schizophrenic patients to equivalent doses of haloperidol, remoxipride and sulpiride].
    Liu KL; Lung FW
    Kaohsiung J Med Sci; 1996 Dec; 12(12):685-90. PubMed ID: 9011126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A risk-benefit assessment of sulpiride in the treatment of schizophrenia.
    Mauri MC; Bravin S; Bitetto A; Rudelli R; Invernizzi G
    Drug Saf; 1996 May; 14(5):288-98. PubMed ID: 8800626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amenorrhoea - consequence of combined treatment with sulpiride and risperidone in a patient suffering from schizophrenia.
    Peitl MV; Pavlović E; Peitl A; Peitl V
    Psychiatr Danub; 2010 Mar; 22(1):123-4. PubMed ID: 20305607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antiemetic effect of the levo isomer of sulpiride (L-sulpiride) in humans].
    Schettini G; Mastronardi P; Scanni E; Pinto M; Forgione A; Florio T; Savastano S; Merola B; Lombardi G; Mazzarella B
    Minerva Anestesiol; 1989 May; 55(5):239-43. PubMed ID: 2601863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single-blind comparison of bromperidol and sulpiride in hospitalized schizophrenics.
    Yamagami S; Hirayama E; Mui K; Okuno M; Kioka T; Soma T; Ohno K
    Acta Psychiatr Belg; 1993; 93(4):236-44. PubMed ID: 7913572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sulpiride in psychiatric practice].
    Faltus F; Jirák R; Pavlovský P
    Cesk Psychiatr; 1989 Jun; 85(3):145-9. PubMed ID: 2766392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neuroendocrine effects of sulpiride].
    Buvat-Herbaut BJ
    Lille Med; 1979 Nov; Suppl 1():37. PubMed ID: 553217
    [No Abstract]   [Full Text] [Related]  

  • 13. Sulpiride: an antipsychotic with selective dopaminergic antagonist properties.
    Caley CF; Weber SS
    Ann Pharmacother; 1995 Feb; 29(2):152-60. PubMed ID: 7756714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between prolactin levels and subjective endocrine-related adverse effects in patients with schizophrenia receiving long-term treatment with amisulpride.
    Kim EY; Kim SH; Lee NY; Jung DC; Kim YS; Ahn YM
    Pharmacopsychiatry; 2012 Mar; 45(2):57-63. PubMed ID: 22411694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sulpiride: a neuroleptic agent of new generation with unique pharmacological qualities and rather wide range of clinical applications].
    Pawłowski L
    Psychiatr Pol; 1993; 27(2):199-205. PubMed ID: 8104350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes in the endocrine system in the course of sulpiride therapy].
    Roś LT
    Pol Merkur Lekarski; 2001 Dec; 11(66):532-4. PubMed ID: 11899856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopaminergic deficit and the role of amisulpride in the treatment of schizophrenia.
    Kasper S
    Int Clin Psychopharmacol; 2002 Dec; 17 Suppl 4():S19-26. PubMed ID: 12685918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ultrastructural study of stimulation induced by sulpiride on prolactin and gonadotrope cells of hypophysis in male and female rats (author's transl)].
    Stefan Y; Benakis A
    Ann Endocrinol (Paris); 1976; 37(5):375-88. PubMed ID: 1020923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical-neuroleptic investigation of N-((1-ethyl-pyrrolidine-2-yl)-methyl)-2-methoxy-5-sulfamyl-benzamide-neuroleptic sulpiride (Dogmatil) in acutly ill schizophrenics].
    Haase HJ; Floru L; Ulrich F
    Int Pharmacopsychiatry; 1974; 9(2):77-94. PubMed ID: 4603413
    [No Abstract]   [Full Text] [Related]  

  • 20. [1st results in the treatment of schizophrenic syndromes using sulpiride].
    Colucci D'Amato C; Luciano LR
    Acta Neurol (Napoli); 1973; 28(6):714-29. PubMed ID: 4593209
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.